Skip to main content
. 2023 May 30;11(5):e5033. doi: 10.1097/GOX.0000000000005033

Table 3.

Postoperative Management

Consideration N (%)
Timing to restart estrogen
 N/A 6 (35.3%)
 POD 1* 1 (5.9%)
 POD 2 1 (5.9%)
 POD 3 1 (5.9%)
 POD 5 1 (5.9%)
 POD 7–10 5 (29.4%)
 POD 11–20 2 (11.8%)
Drain use
 Yes 15 (88.2%)
Drain placement
 Groin 1 (5.9%)
 Labia 10 (58.9%)
 Suprapubic 6 (35.3%)
 Gluteal 2 (11.8%)
Number of drains
 One JP/Blake 4 (23.5%)
 Two JP/Blakes 7 (41.2%)
 Two Penrose 3 (17.6%)
Packing
 Yes 16 (94.1%)
 Prosthetic 2 (11.8%)
 Packing sewn in place 7 (41.2%)
Length of stay
 Overnight 1 (5.9%)
 POD 2–4 5 (29.4%)
 POD 5 4 (23.5%)
 POD 6–9 7 (41.2%)
Use of chemoprophylaxis for VTE
 Yes 15 (88.2%)
 None/unknown 2 (11.8%)
Length of chemoprophylaxis§
 Day of surgery only 3 (27.7%)
 POD 1 2 (18.2%)
 POD 7 1 (9.1%)
 While inpatient 5 (45.5%)
Packing removal timing
 POD 5–6 14 (82.4%)
 POD 7–9 3 (17.6%)
Foley removal timing
 POD 5–6 12 (70.6%)
 POD 7–10 5 (29.4%)
 Foley kept in longer than packing 7 (41.2%)
Dilation initiation timing
 POD 5–6 9 (52.9%)
 POD 7–10 6 (35.3%)
 POD 11–14 2 (11.8%)
Dilator size to start
 Smallest 7 (41.2%)
 Largest that will fit 10 (58.8%)
 Scheduled upsizing of dilator 7 (41.2%)
Vaginal rinses
 Yes 13 (76.5%)
*

One respondent holds estrogen on the day of surgery only.

Five respondents put drains in multiple anatomic positions.

One respondent sometimes uses packing and other times a prosthetic.

§

Percentage is based on the 14 respondents who use chemoprophylaxis.

One respondent said it depends on the outcome with bolster takedown.